<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>The Prozac Debate</title>
    <meta content="LTR234811" name="slug"/>
    <meta content="25" name="publication_day_of_month"/>
    <meta content="7" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Tuesday" name="publication_day_of_week"/>
    <meta content="Science Desk" name="dsk"/>
    <meta content="3" name="print_page_number"/>
    <meta content="F" name="print_section"/>
    <meta content="6" name="print_column"/>
    <meta content="Science; Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1217642"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Mental Health and Disorders</classifier>
        <classifier class="indexing_service" type="descriptor">Depression (Mental)</classifier>
        <classifier class="indexing_service" type="descriptor">Antidepressants</classifier>
        <classifier class="indexing_service" type="descriptor">Prozac (Drug)</classifier>
        <person class="indexing_service">gindi, michael m (dr)</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Antidepressants</classifier>
        <classifier class="online_producer" type="general_descriptor">Depression (Mental)</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Mental Health and Disorders</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000725T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9D04E0DB103AF936A15754C0A9669C8B63" item-length="187" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>The Prozac Debate</hl1>
      </hedline>
      <abstract>
        <p>Dr Michael M Gindi letter on July 18 article holds over-prescription of Prozac is symptom of our times; photo</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>Setting aside the latest controversy over Prozac's potential side-effects, it is important to note that many practicing clinicians still consider the over-prescription of Prozac to be as much a symptom of our times as it is a cure for our symptoms.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>Setting aside the latest controversy over Prozac's potential side-effects, it is important to note that many practicing clinicians still consider the over-prescription of Prozac to be as much a symptom of our times as it is a cure for our symptoms.</p>
        <p>In an era when the courts routinely reward personal irresponsibility, when everything from a foam coffee cup to a Champagne cork must sport a warning label alerting us to the obvious, we ought not be surprised when many physicians indiscriminately prescribe a passive feel-good drug instead of encouraging patients to actively look at their lives.</p>
        <p>Recently, a patient came to me after quitting an H.M.O. psychiatrist who immediately cost-effectively ''Zacked'' him for his depressive tendencies. The patient said: ''I began to realize that maybe I should feel a little sad about continuing to wreck my marriage with a series of illicit affairs. On Prozac, I was starting to feel just fine about it.''</p>
        <p>DR. MICHAEL M. GINDI  New York</p>
      </block>
    </body.content>
  </body>
</nitf>
